Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Liver Int. 2019 Oct;39(10):1884-1894. doi: 10.1111/liv.14184. Epub 2019 Jul 10.
BACKGROUND & AIMS: Little is known about the impact of metabolically healthy obesity on fibrosis progression in non-alcoholic fatty liver disease (NAFLD). We investigated the association of body mass index (BMI) category, body fat percentage and waist circumference with worsening of noninvasive fibrosis markers in metabolically healthy and unhealthy individuals with NAFLD.
A cohort study was performed on 59 957 Korean adults with NAFLD (13 285 metabolically healthy and 46 672 metabolically unhealthy individuals) who were followed for a median of 7.7 years. Being metabolically healthy was defined as not having any metabolic syndrome component and having a homoeostasis model assessment of insulin resistance <2.5. Progression from low to intermediate or high probability of advanced fibrosis was assessed using the NAFLD fibrosis score (NFS).
During 339 253.1 person-years of follow-up, 9857 subjects with low NFS at baseline progressed to intermediate or high NFS. Among metabolically healthy individuals, the multivariable-adjusted HRs (95% CI) for NFS worsening comparing BMIs 23-24.9, 25-29.9 and ≥30 with a BMI of 18.5-22.9 kg/m were 1.19 (1.00-1.42), 1.79 (1.52-2.10) and 3.52 (2.64-4.69), respectively, whereas the corresponding HRs (95% CI) in metabolically unhealthy individuals were 1.37 (1.24-1.52), 2.18 (1.99-2.39) and 4.26 (3.83-4.75). A similar trend was observed in the analyses using body fat and waist circumference.
In the large-scale cohort of young and middle-aged individuals with NAFLD, BMI was positively associated with worsening of noninvasive fibrosis marker regardless of metabolic health status. Excess adiposity per se, even without accompanying metabolic health status, may contribute to fibrosis progression in NAFLD.
代谢健康肥胖对非酒精性脂肪性肝病(NAFLD)纤维化进展的影响知之甚少。我们研究了代谢健康和不健康的 NAFLD 个体中,体重指数(BMI)类别、体脂肪百分比和腰围与非侵入性纤维化标志物恶化的关系。
对 59957 名韩国 NAFLD 成年人(13285 名代谢健康和 46672 名代谢不健康个体)进行了队列研究,中位随访时间为 7.7 年。代谢健康定义为没有任何代谢综合征成分,且稳态模型评估的胰岛素抵抗<2.5。使用非酒精性脂肪性肝病纤维化评分(NFS)评估从低概率到中或高概率进展为晚期纤维化的情况。
在 339253.1 人年的随访期间,基线时 NFS 较低的 9857 例患者进展为中或高 NFS。在代谢健康个体中,与 BMI 为 18.5-22.9kg/m 的个体相比,BMI 为 23-24.9kg/m、25-29.9kg/m 和≥30kg/m 的个体 NFS 恶化的多变量调整 HR(95%CI)分别为 1.19(1.00-1.42)、1.79(1.52-2.10)和 3.52(2.64-4.69),而代谢不健康个体的相应 HR(95%CI)分别为 1.37(1.24-1.52)、2.18(1.99-2.39)和 4.26(3.83-4.75)。在使用体脂肪和腰围的分析中也观察到类似的趋势。
在大规模的年轻和中年 NAFLD 患者队列中,BMI 与非侵入性纤维化标志物的恶化呈正相关,无论代谢健康状况如何。即使没有伴随的代谢健康状态,过多的脂肪堆积本身可能会导致 NAFLD 的纤维化进展。